Skip Ribbon Commands
Skip to main content


Your source for Charleston real estate trends and insights

Stay up to date on Charleston real estate trends in all property types. JLL researchers cover topics important to you and your real estate decisions, whether you’re seeking corporate, tenant or investor insight.



 Latest research from the Carolinas market



Charlotte Craft Beer Guidebook - Summer 2018/united-states/en-us/research/9320/us-charlotte-craft-beer-guidebook-summer-2018-jllCharlotte Craft Beer Guidebook - Summer 2018​The number of operating craft breweries in North Carolina has grown over 300% since 2011. There is no question that craft beer has gained immense popularity in Charlotte.
Greensboro Industrial Insight - Q2 2018/united-states/en-us/research/9288/industrial-insight-greensboro-industrial-insight-q2-2018-jllGreensboro Industrial Insight - Q2 2018A quarterly summary of local economic and industrial real estate market conditions for individual metro areas in the United States. The report includes key market indicators, tenant and landlord perspectives, and future looking analysis.

 Latest U.S. research reports



United States Employment Update - September 2018/united-states/en-us/research/9338/us-employment-update-september-2018-jllUnited States Employment Update - September 2018​With 201,000 net new jobs, August rebounded after a slower July, aided by growth in a variety of sectors, most notably a resurgence in transportation, warehousing and wholesale trade.
United States Retail Outlook - Q2 2018/united-states/en-us/research/9336/us-retail-outlook-q2-2018-jllUnited States Retail Outlook - Q2 2018​As anchors like Sears and Bon-Ton and big boxes like Toys "R" Us closed their doors in the second quarter, retail absorption has softened, as expected, and vacancy has inched up slightly.
United States Life Sciences Outlook - 2018/united-states/en-us/research/9244/us-life-sciences-outlook-2018-jllUnited States Life Sciences Outlook - 2018Life Sciences innovation is evolving at a breathtaking pace. The largest players, mid-tier companies and small startups are leveraging unprecedented mechanisms to create novel medicines.